Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 9 of 9
Full-Text Articles in History
Oncolog, Volume 62, Number 05-06, May - June 2017, Joe Munch, Bryan Tutt, Kathryn Hale
Oncolog, Volume 62, Number 05-06, May - June 2017, Joe Munch, Bryan Tutt, Kathryn Hale
OncoLog MD Anderson's Report to Physicians (All issues)
- Chimeric Antigen Receptor-Directed Natural Killer Cells for B Cell Malignancies: New take on an experimental therapy holds promise for patients with acute lymphoblastic leukemia, chronic lymphocytic leukemia, other lymphoid cancers.
- Preoperative Exercise Program for Pancreatic Cancer Patients: Prehabilitation regimen to improve functional status during chemotherapy evaluated in clinical trials.
- Neoadjuvant Immunotherapy for Non-Small Cell Lung Cancer: Clinical Trial will evaluate immune checkpoint inhibitors in patients with operable early-stage disease.
- HOUSE CALL: Genetic Screening for Hereditary Cancer Syndromes: Genetic counseling, testing help people assess, manage cancer risk
Oncolog, Volume 58, Number 10, October 2013, Bryan Tutt, Sunni Hosemann, C. Wilcox
Oncolog, Volume 58, Number 10, October 2013, Bryan Tutt, Sunni Hosemann, C. Wilcox
OncoLog MD Anderson's Report to Physicians (All issues)
- Sentinel Lymph Node Dissection After Neoadjuvant Chemotherapy for Node-Positive Breast Cancer May replace Axillary Dissection for Some Patients: Sentinel lymph node dissection has become a standard staging tool for breast cancer patients with no clinical eveidence of disease in the lymph nodes
- INBRIEF: miR-200 MicroRNAs Slow Tumor Growth
- Compass: Resectable or Borderline Resectable Pancreatic Adenocarcinoma: Initial Treatment Options-Neoadjuvent chemoradiation may benefit patients with resectable disease
- HOUSE CALL: Hereditary Cancers: Genetic screening can give valuable information
Oncology, Volume 56, Number 08, August 2011, Stephanie Deming, Sunni Hosemann
Oncology, Volume 56, Number 08, August 2011, Stephanie Deming, Sunni Hosemann
OncoLog MD Anderson's Report to Physicians (All issues)
- Addressing the Cardiac Complications of Cancer Treatment: Patients with cancer surviving longer than ever after treatment, and new targeted therapy agents are being introduced into the clinic with increasing frequency. These advances are cause for optimism, but they have also led to an increased incidence of cardiac complications of cancer therapy
- Compass: Early- and Intermediate-Stage Gastric Cancer: Neoadjuvant of adjuvant treatments offer higher cure rates than surgery alone
- HOUSE CALL: Managing Disease-Related Fatigue- Patients and doctors offer can make fatigue less severe
Oncolog Volume 55, Number 08, August 2010, Bryan Tutt, John Lebas
Oncolog Volume 55, Number 08, August 2010, Bryan Tutt, John Lebas
OncoLog MD Anderson's Report to Physicians (All issues)
- Therapeutic Vaccines against Cancer: Clinical trials of thrapeutic vaccines in cancer patients yield positive results
- Findings Could Altere Chronic Myelogenous Leukemia Treatment: Phase III trials show newer drugs yield better responses than imatinib
- INBRIEF: Vandetanib Shows Benefit When Combined with Docetaxel for Lung Cancer/ HPV-Positive Tumor Status Indicates Better Prognosis in Patients with Oropharyngeal Cancer
- HOUSE CALL: Understanding the Benefits and Risks of Massage
Oncolog Volume 53, Number 03, March 2008, John Lebas, Gordon B. Mills Md, Phd
Oncolog Volume 53, Number 03, March 2008, John Lebas, Gordon B. Mills Md, Phd
OncoLog MD Anderson's Report to Physicians (All issues)
- In Search of the Answer
- DiaLog: Mapping the Cancer Genome, by Gordon Mills, MD, PhD, Director, Kleberg Center for Molecular Markers, Chair, Department of Systems Biology
- House Call: The Basics of Biopsies
Oncolog, Volume 47, Number 06, June 2002, Kate O'Suilleabhain, Dawn Chalaire, Shellie M. Scott Bs
Oncolog, Volume 47, Number 06, June 2002, Kate O'Suilleabhain, Dawn Chalaire, Shellie M. Scott Bs
OncoLog MD Anderson's Report to Physicians (All issues)
- Drug Development Program Paves the Way for FDA Approval of New Agents
- Pediatric New Agents Working Group Advances the Study of Novel Treatments in Young Patients
- DiaLog: Patients and Physicians: Partners in Health Care, by Shellie M. Scott, BS, Physician Assistant, Department of Urology
- House Call: Taking a More Active Role in Your Own Health Care
- As Population of Cancer Survivors Grows, Studies of Long-Term Health Effects Become More Critical, Researchers Say
Oncolog, Volume 44, Number 04, April 1999, Dawn Chalaire
Oncolog, Volume 44, Number 04, April 1999, Dawn Chalaire
OncoLog MD Anderson's Report to Physicians (All issues)
- Pancreatic Tumor Team Studies Disease Mechanisms, Reverses Conventional Approach
- Patient Helps Underwrite Familial Cancer Study
- Stomach Cancer Protocols Offer Options
- Gastric Cancer's Low Survival Rate and High Relapse Rate Challenge Physicians
- House Call: Environmental Carcinogens: Fact and Fiction
- Protocols: Pancreatic Cancer Protocol Options Include Gemdtabine and Marimastat
Oncolog, Volume 30, Number 04, October-December 1985, Oncolog Staff
Oncolog, Volume 30, Number 04, October-December 1985, Oncolog Staff
OncoLog MD Anderson's Report to Physicians (All issues)
- Endocrine Therapy for Prostatic Cancer Can Replace Orchiectomy and Estrogens
Newsletter, Volume 07, Number 02, September 1962
Newsletter, Volume 07, Number 02, September 1962
Newsletter: A Report to Physicians of Texas
- International Cancer Congress Held in Moscow
- Treatment Results Analysis
- Patient care in Advanced Cancer
- Autotransplanted Adenocarcinoma X-Ray Response
- Combined Drug and Radiation therapy Evaluated
- Polyoma-Infected Cells Studied
- Pelvic Tumor Management with 22 Mev Betatron
- Hamster Tumors Induced by Human Adenovirus
- Nucleic Acid Effect on Tumor Cells
- Antifibrin Antibody Localization
- Enzymatic Changes in Rat Livers
- Tissue Changes After Perfusion
- Staging and End Results Reporting